Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. - Wikidata - awgldk - TriplyDB

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

http://www.wikidata.org/entity/Q36745357

about

B cell regulation of the anti-tumor response and role in carcinogenesis Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells The roles of regulatory B cells in cancer Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity Generation and identification of tumor-evoked regulatory B cells Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.B cell regulation of anti-tumor immune response.Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-RasG12V-Induced Squamous Tumors.Potential importance of B cells in aging and aging-associated neurodegenerative diseases.Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases B cell regulation in cancer and anti-tumor immunity.CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remission.Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients.How much sunlight is enough?B cells for cancer immunotherapy.B lymphocytes and cancer: a love-hate relationship.IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.Introduction: Regulatory B Cell Special Issue-making all the pieces fit.

P2860

Q26738867-4D199323-8566-4DD4-8C90-7F21ADDFB1D3 Q28551184-DD51A5EE-BDBB-455F-9DCC-3EB0EE729BC3 Q33765986-7F0CD399-E7E8-4BC4-A7C4-FDB5773EFA64 Q34103969-FAF49D00-1C0F-45A0-A421-A5B858D9F3D0 Q34106843-CD7C507D-E769-485C-ACFA-3D82F4AADE99 Q34138195-A4290C5A-6777-4BF1-A45B-543F17B98709 Q36021465-8E085E24-AB56-45BA-886E-F8311A2AC10D Q36093770-8DA187EE-9478-40EA-9030-713D1D072FE7 Q36629387-7BF7820F-2ED3-4FCE-AAEF-6FA91C2984CE Q36767874-F5368FA6-C37E-42C1-9625-8FDF7A8E7F76 Q37227553-B7061434-2180-4D0D-AB91-320D9F9E6FF3 Q37352695-31ADC0AC-4AE7-49D9-952A-6575EDDA0D02 Q37616487-8A047DBF-A111-4D52-8A70-8071B91A983A Q38167668-E85FAEDB-56A2-40D7-AF1D-DADD1DD0526A Q38170150-B73F7ED1-479E-4697-BD92-A3D6C2BEE0DC Q38201655-9D05CDA5-48F9-47E4-A9A6-27CB2FF6C825 Q38991275-DDD85783-50BE-42FE-BB8F-F8222E830A8A Q39084950-FD7A8371-8B0E-4D6B-AFA1-6CB0483C5E51 Q39109245-EA203724-AB7F-4C9D-866A-793BBEE1C1A9 Q39381508-F83FE06D-F6C9-470E-8E67-81108FADF868 Q39720114-3A7FC83D-9051-4D36-8D6F-F3AC9C452CE0 Q40167058-8703E0DC-5DE3-435B-8EAA-4C71572CF57E Q42217642-EF570C8A-AF31-4506-9289-76FF2F18C441 Q42553558-89C796DD-A11E-413E-ABFE-A00EC5C0DC71 Q44779139-D1ACAB3A-6278-4CAA-A8D3-3CFB4935EC1C Q47098673-29073D11-F032-48DD-B41E-F4D1E012EFD5 Q53327428-8D96BA9A-B15F-4355-A116-58A96B061E34

P2860

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

http://www.wikidata.org/entity/Q36745357

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L.

@ast

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L.

@en

type

label

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L.

@ast

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L.

@en

prefLabel

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L.

@ast

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L.

@en

P1433

Q36745357-82AA5A73-47C6-412E-937F-B473C948A4DD

P1476

Q36745357-9213D159-BE2B-474D-B718-E56009960664

P2093

Q36745357-01C2AF6E-EFAC-4F2E-AB76-ECF8E295C35E

Q36745357-028F7DAB-327B-4195-B369-FD6CA133867F

Q36745357-343AB30D-0CBB-48FA-83CB-164F6F5E59CC

Q36745357-37955FDD-1621-4574-BC1E-2FAE79FD90B9

Q36745357-7158B876-7DBC-4F8D-9437-54D5288B3EBD

Q36745357-8E27D362-B196-4FCC-8803-E176B595787E

Q36745357-AC15E7B9-C1DB-4FEE-BF88-BBEA58ED03A7

Q36745357-C7AFC6D0-0F18-4387-844B-77F8AD861199

Q36745357-ECA774E7-C325-463C-A09A-6CB49A7BC830

P2860

Q36745357-0016B85C-5CB9-4947-9A36-68A4832176AD

Q36745357-06A1BB59-7489-43A8-9E4B-E9B04CCBFBB7

Q36745357-084E9E11-58CF-4F4F-A2DD-817D7FDC2E06

Q36745357-0A9E715F-394D-4DC9-A851-4EB98A6D7E0A

Q36745357-0E62ED32-65B3-409C-ADB7-E9AF355F373F

Q36745357-1F54F15B-F093-4D20-BD09-9B5AB4BD7F5B

Q36745357-2CBCB049-C1CE-43B1-BC31-4ED2DB366E3D

Q36745357-34AE30F5-EE6C-4BFC-AAB6-B1B9F6C53536

Q36745357-35E2DAD6-CFFF-467D-AE33-98E08D30BCC4

Q36745357-37138B19-DCD8-4C6E-A059-967A34F75201

P304

Q36745357-549CB09A-25C6-4D2B-801E-398B3AB3D93E

P31

Q36745357-7E524484-7F86-45AE-9854-18AAFBF52357

P356

Q36745357-7A7F7AF0-CB00-41C4-81C2-6AA54C190D2E

P407

Q36745357-EFA0B991-A91C-4D17-9A91-344B76F25D0F

P433

Q36745357-FE21FAEC-93E5-4EA9-8E14-2F6CB4C09DFE

P478

Q36745357-ECE43CF0-98A8-4070-9036-8FB93444C172

P50

Q36745357-18E3FE16-91EC-402E-B605-2D1E7E5C8CCE

P577

Q36745357-1407F499-D9D2-4821-8FEF-1CD4B62E0D8E

P698

Q36745357-0D460127-1459-4619-BBD0-C92ADB2AB6C4

P932

Q36745357-77B4A2AF-6613-4277-B124-A06A814A15D4

P356

0008-5472.CAN-12-4184

P1433

Cancer Research

P1476

Anti-CD20 antibody promotes ca ...... low levels of CD20 and CD137L

@en

P2093

Andrew C Chan

http://www.w3.org/2001/XMLSchema#string

Arya Biragyn

http://www.w3.org/2001/XMLSchema#string

Catalina Lee Chang

http://www.w3.org/2001/XMLSchema#string

Charles Hesdorffer

http://www.w3.org/2001/XMLSchema#string

Jinping Lai

http://www.w3.org/2001/XMLSchema#string

Katarzyna Wejksza

http://www.w3.org/2001/XMLSchema#string

Maria Merino

http://www.w3.org/2001/XMLSchema#string

Robert P Wersto

http://www.w3.org/2001/XMLSchema#string

Ronald E Gress

http://www.w3.org/2001/XMLSchema#string

P2860

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

T cell co-stimulatory molecules other than CD28.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice.

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.

P304

2127-2138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-4184

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23365136

http://www.w3.org/2001/XMLSchema#string

P932

3618504

http://www.w3.org/2001/XMLSchema#string